NASDAQ:KPTI - Karyopharm Therapeutics Inc.
$8.45
 $0.15
+1.81%
12:10PM EDT
2019-07-22
Karyopharm Therapeutics Inc. is a clinical-stage pharmaceutical company. The Company is focused on the discovery, development and commercialization of drugs directed against nuclear transport and related targets for the treatment of cancer and other diseases. It has discovered and is developing small molecule Selective Inhibitor of Nuclear Export (SINE) compounds that inhibit the nuclear export protein, XPO1. The Company's lead drug candidate, selinexor (KPT-330), is an orally administered agent for the treatment of cancer indications with unmet clinical need, mainly hematologic malignancies. It is also engaged in the clinical development of selinexor in various solid tumor indications. Oral selinexor is being evaluated in multiple later-phase clinical trials in patients with relapsed and/or refractory hematological and solid tumor malignancies. Its lead drug candidate, oral selinexor (KPT-330), as well as verdinexor (KPT-335), KPT-8602 and KPT-9274 are in clinical development. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  KPTI     avg for
industry  
  avg for
sector  
42 stocks weight:  27. 36   217. 37   399. 45  
42 stocks rank:  2. 93 K 1. 27 K 716. 99  
# analyst opinions:  8. 00   13. 21   13. 71  
mean recommendation:  1. 60   2. 10   2. 04  

quick ratio:  6. 03   5. 49   1. 88  
current ratio:  6. 19   5. 87   2. 36  

target price low:  10. 19   83. 44   114. 90  
target price avg:  11. 00   106. 20   137. 90  
target price high:  19. 75   132. 30   158. 97  
1-yr high:  21. 18   111. 86   142. 57  
last close:  8. 30   86. 79   125. 44  
50-day avg:  6. 22   86. 68   122. 63  
200-day avg:  7. 95   89. 22   121. 38  
1-yr low:  4. 12   69. 78   100. 51  
volume:  2. 25 M 2. 62 M 3. 43 M
50-day avg volume:  2. 61 M 3. 20 M 4. 16 M
200-day avg volume:  1. 52 M 2. 99 M 4. 75 M

1-day return:  -0. 84 % -1. 30 % -0. 99 %
this week return:  3. 36 % 0. 45 % -0. 20 %
12-wk return:  71. 13 % 0. 94 % 4. 84 %
52-wk return:  -58. 94 % -1. 30 % 10. 55 %

enterprise value (EV):  335. 39 M 45. 10 B 122. 38 B
market cap:  509. 44 M 38. 96 B 108. 40 B
EBITDA:  -205. 05 M 4. 20 B 8. 19 B
enterprise multiple (EV/EBITDA):  -1. 64   5. 38   11. 93  
enterprise/revenue (EV/R):  16. 37   57. 92   10. 21  
total revenue:  20. 49 M 9. 91 B 39. 98 B
total debt:  120. 20 M 10. 90 B 17. 48 B
debt/equity:  99. 11   57. 18   120. 05  
net income (common):  -206. 11 M 2. 07 B 4. 05 B

shares outstanding:  49. 69 M 538. 09 M 1. 24 B
shares:  43. 03 M 548. 00 M 1. 22 B
shares short:  8. 76 M 10. 98 M 11. 87 M
shares short prior month:  8. 04 M 9. 32 M 12. 05 M
short ratio:  7. 94   5. 60   3. 34  
short % of float:  17. 87 % 6. 48 % 2. 64 %
total cash/share:  4. 34   10. 98   9. 19  
total cash:  264. 42 M 5. 93 B 6. 10 B
free cash flow:  -122. 04 M 2. 92 B 4. 55 B
operating cash flow:  -191. 09 M 3. 80 B 5. 78 B

book value:  1. 99   13. 35   27. 45  
price/book:  4. 16   4. 60   8. 78  
gross profits:  -131. 04 M 7. 44 B 36. 13 B
operating margins:  -1004. 65 % -308. 40 % -28. 55 %
EBITDA margins:  0. 00 % 13. 17 % 23. 38 %
profit margins:  0. 00 % 10. 44 % 14. 18 %
gross margins:  0. 00 % 35. 80 % 55. 40 %

1-yr max volatility:  43. 25 % --- ---
1-yr mean volatility:  3. 34 % 1. 66 % 1. 03 %

1-yr EPS:  -3. 46   2. 10   4. 23  
forward EPS:  -2. 75   3. 45   7. 10  
P/E:  -2. 40   1. 90   32. 10  
forward P/E:  -3. 04   6. 46   15. 47  
PE/G:  0. 02   0. 70   -0. 54  
growth:  -98. 50 % 265. 63 % 79. 11 %
earnings high:  -0. 73   0. 89   1. 68  
earnings avg:  -0. 98   0. 70   1. 57  
earnings low:  -1. 15   0. 46   1. 46  
revenue high:  500. 00 K 2. 57 B 11. 07 B
revenue avg:  90. 00 K 2. 51 B 10. 91 B
revenue low:  -0. 00   2. 45 B 10. 73 B
return on assets:  -59. 35 % -2. 34 % 5. 28 %
return on equity:  -190. 13 % -90. 08 % 133. 53 %
revenue growth:  -98. 50 % 265. 25 % 73. 68 %
revenue/share:  0. 34   12. 72   60. 04  

beta (1yr vs S&P500):  2. 14   1. 27   0. 91  
sharpe (1yr):  -0. 48   0. 16   0. 77  

held % insiders:  18. 45 % 6. 06 % 3. 29 %
held % institutions:  92. 99 % 78. 22 % 69. 37 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-21 : KPTI
.    109.083 =       109.083 :: --> INITIAL WEIGHT <--
.    - 3.457 =       105.626 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 2.028 =       214.231 :: P/E factor
.    x 2.209 =       473.227 :: PE/G factor
.    x 1.366 =       646.276 :: beta factor
.     x 0.81 =       523.432 :: sharpe factor
.    x 2.945 =      1541.659 :: current ratio factor
.    x 1.095 =      1687.991 :: quick ratio factor
.    x 1.061 =      1791.136 :: short ratio factor
.    x 1.283 =      2297.269 :: EV/R factor
.    x 1.051 =      2414.387 :: price-to-book factor
.    x 0.699 =       1686.61 :: debt-to-revenue factor
.    x 1.126 =      1898.343 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.121 =      4025.993 :: sector+industry 1-year gains factor
.    x 1.009 =       4063.95 :: industry 12-weeks return factor
.    x 1.308 =      5315.194 :: industry 2-weeks return factor
.    x 1.056 =      5612.172 :: 5-day avg > 200-day avg
.    x 2.317 =     13002.821 :: 5-day avg > 50-day avg
.    x 0.961 =     12493.668 :: "drift" penalty 2 days ago
.    x 0.995 =     12435.747 :: "drift" penalty 4 days ago
.    / 2.163 =      5750.132 :: overall "drift" factor
.    x 0.307 =      1767.601 :: largest single-day jump factor
.    x 0.113 =       199.054 :: low price factor
.    x 1.518 =       302.152 :: notable returns + performance factor
.    x 2.412 =       728.843 :: performance vs s&p500 factor
.                               --> PROJECTIONS <--
.    x 0.725 =        528.19 :: forward EPS factor
.      x 0.9 =        475.35 :: forward P/E factor
.    x 1.185 =       563.153 :: industry recommendation factor
.    x 2.844 =      1601.769 :: company recommendation factor
.    x 1.003 =      1606.199 :: factor historical industry gain for week 29
.    x 1.591 =      2556.135 :: target low factor
.     x 1.19 =        3042.1 :: target mean factor
.    x 1.049 =      3192.168 :: target high factor
.   x 10.552 =     33683.084 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =        13.547 :: reduced for readability
.   + 13.812 =        27.359 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                     27.359 :: FINAL WEIGHT for NASDAQ:KPTI


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org